World's Best Scientists 2026 revealed!
Christoph Schmid

Christoph Schmid

Christoph Schmid publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Christoph Schmid sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

The last bar groups every scientist with 1,796 publications or more.

Christoph Schmid D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Christoph Schmid sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

The last bar groups every scientist with 217 D-Index or more.

Overview

Christoph Schmid is affiliated with the University of Augsburg in Germany and has contributed extensively to the field of medicine, with a particular focus on hematology, immunology, and oncology. Their body of work encompasses a variety of research areas related to blood cancers and transplant medicine.

The primary fields of study for Schmid include:

  • Medicine

Their research further delves into several specialized subfields:

  • Hematology
  • Immunology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Molecular Biology

Key topics Schmid has addressed involve:

  • Acute Myeloid Leukemia Research
  • Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia research
  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Chronic Myeloid Leukemia Treatments

Schmid's recent notable publications include:

  • "Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN)", 2020, Journal of Clinical Oncology
  • "Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients", 2020, Bone Marrow Transplantation
  • "Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation", 2020, Haematologica
  • "Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia", 2021, Bone Marrow Transplantation
  • "Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years", 2020, Clinical Cancer Research

Frequent co-authors include:

  • Gesine Bug
  • Mohamad Mohty
  • Arnon Nagler
  • Myriam Labopin
  • Fabio Ciceri

Schmid regularly publishes in several prominent scientific journals, with the most common venues being:

  • Blood
  • Bone Marrow Transplantation
  • Haematologica
  • International Journal of Molecular Sciences
  • Annals of Hematology

Best Publications

  • Actions of Insulin-Like Growth Factors

    E R Froesch;C Schmid;J Schwander;J Zapf

  • Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.

    Peter Kurtzhals;Lauge Schäffer;Anders Sørensen;Claus Kristensen

  • Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates.

    H P Guler;J Zapf;C Schmid;E R Froesch

  • Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

    Christoph Schmid;Myriam Labopin;Arnon Nagler;Martin Bornhäuser

  • Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)

    Andreas Burchert;Gesine Bug;Lea V. Fritz;Jürgen Finke

  • Sequential Regimen of Chemotherapy, Reduced-Intensity Conditioning for Allogeneic Stem-Cell Transplantation, and Prophylactic Donor Lymphocyte Transfusion in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

    Christoph Schmid;Michael Schleuning;Georg Ledderose;Johanna Tischer

  • Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation.

    Christoph Schmid;Michael Schleuning;Rainer Schwerdtfeger;Bernd Hertenstein

  • Impact of thyroid dysfunction on serum cystatin C

    Manuel Fricker;Peter Wiesli;Peter Wiesli;Michael Brändle;Michael Brändle;Beat Schwegler;Beat Schwegler

  • 1 Biological and immunological properties of insulin-like growth factors (IGF) I and II

    J. Zapf;C.H. Schmid;E.R. Froesch

  • Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

    Martin Bornhäuser;Joachim Kienast;Rudolf Trenschel;Andreas Burchert

  • Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats.

    J Zapf;C Hauri;M Waldvogel;E Futo

  • A novel hierarchical prognostic model of AML solely based on molecular mutations

    Vera Grossmann;Susanne Schnittger;Alexander Kohlmann;Christiane Eder

  • Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

    Nimitha R Mathew;Nimitha R Mathew;Francis Baumgartner;Lukas Braun;David O'Sullivan

  • Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation

    Christoph Schmid;Myriam Labopin;Arnon Nagler;Dietger Niederwieser

  • Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast.

    M C Kiefer;C Schmid;M Waldvogel;I Schläpfer

  • ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome

    S Schnittger;C Eder;S Jeromin;T Alpermann

  • Serum cystatin C is sensitive to small changes in thyroid function

    Peter Wiesli;Beat Schwegler;Giatgen A. Spinas;Christoph Schmid

  • Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT.

    P. Tsirigotis;M. Byrne;C. Schmid;Frédéric Baron

  • Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia.

    J Zapf;C Schmid;H P Guler;M Waldvogel

  • Matched Unrelated or Matched Sibling Donors Result in Comparable Survival After Allogeneic Stem-Cell Transplantation in Elderly Patients With Acute Myeloid Leukemia: A Report From the Cooperative German Transplant Study Group

    Johannes Schetelig;Martin Bornhäuser;Christoph Schmid;Bernd Hertenstein

Frequent Co-Authors

Myriam Labopin
Myriam Labopin Université Paris Cité
Arnon Nagler
Arnon Nagler Sheba Medical Center
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center
Arnold Ganser
Arnold Ganser Hannover Medical School
Jan J. Cornelissen
Jan J. Cornelissen Erasmus University Rotterdam
Gérard Socié
Gérard Socié Université Paris Cité
Jürgen Finke
Jürgen Finke University of Freiburg
Nicolaus Kröger
Nicolaus Kröger Universität Hamburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t just mean becoming a physician. There are numerous online degree options in healthcare that can support your ambitions. Many students look for the cheapest online health science degree programs to gain foundational knowledge in healthcare management and operations. These affordable options make it easier for learners to get started without a heavy financial burden.

For those interested in advanced leadership roles, consider enrolling in the cheapest online mha programs. These master’s programs prepare graduates for higher-level positions in hospitals, clinics, and other healthcare settings.

If your career goals involve direct patient care at a high level, research the cheapest online bsn to dnp programs to earn a clinical doctorate without relocating or pausing your current job. For nurses interested in mental health, the fastest psych np program options allow you to specialize rapidly and step into high-demand psychiatric nurse practitioner roles.

Online healthcare degrees offer flexible, affordable ways to launch or advance your medical career in the USA. Explore these pathways to find the best fit for your goals.

Best Scientists Citing Christoph Schmid

Trending Scientists

Recently Published Articles